Cargando…
How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing
BACKGROUND: Sampling and testing for SARS‐CoV‐2 is a widely recognized method for identifying patients with COVID‐19. However, there is limited research available on the stability of nucleic acids in viral storage solutions. METHODS: This paper investigates the components that provide better protect...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561591/ https://www.ncbi.nlm.nih.gov/pubmed/37661301 http://dx.doi.org/10.1002/jcla.24956 |
_version_ | 1785117956379770880 |
---|---|
author | Duan, Xiuzhi Huang, Letao Wang, Xuchu Ping, Ying Yu, Pan Liu, Weiwei Xie, Yiyi Tao, Zhihua |
author_facet | Duan, Xiuzhi Huang, Letao Wang, Xuchu Ping, Ying Yu, Pan Liu, Weiwei Xie, Yiyi Tao, Zhihua |
author_sort | Duan, Xiuzhi |
collection | PubMed |
description | BACKGROUND: Sampling and testing for SARS‐CoV‐2 is a widely recognized method for identifying patients with COVID‐19. However, there is limited research available on the stability of nucleic acids in viral storage solutions. METHODS: This paper investigates the components that provide better protection for virus and nucleic acid detection. The study utilized real‐time quantitative fluorescent PCR to detect SARS‐CoV‐2 and evaluate the preservation effect and stability of SARS‐CoV‐2 viral storage solution under various conditions, including different guanidinium salts, brands, and storage conditions. RESULTS: All brands of inactivated virus preservation solutions demonstrated effective preservation and stability. However, 0.5 mol/L guanidine hydrochloride and guanidine isothiocyanate solutions exhibited poor antiseptic effects. Additionally, refrigerated storage showed better preservation compared to room temperature storage. CONCLUSIONS: We recommend using inactivated virus collection solution to preserve and transport samples and testing preferably within 6 hours to reduce false negatives of NAT results. |
format | Online Article Text |
id | pubmed-10561591 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105615912023-10-10 How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing Duan, Xiuzhi Huang, Letao Wang, Xuchu Ping, Ying Yu, Pan Liu, Weiwei Xie, Yiyi Tao, Zhihua J Clin Lab Anal Research Articles BACKGROUND: Sampling and testing for SARS‐CoV‐2 is a widely recognized method for identifying patients with COVID‐19. However, there is limited research available on the stability of nucleic acids in viral storage solutions. METHODS: This paper investigates the components that provide better protection for virus and nucleic acid detection. The study utilized real‐time quantitative fluorescent PCR to detect SARS‐CoV‐2 and evaluate the preservation effect and stability of SARS‐CoV‐2 viral storage solution under various conditions, including different guanidinium salts, brands, and storage conditions. RESULTS: All brands of inactivated virus preservation solutions demonstrated effective preservation and stability. However, 0.5 mol/L guanidine hydrochloride and guanidine isothiocyanate solutions exhibited poor antiseptic effects. Additionally, refrigerated storage showed better preservation compared to room temperature storage. CONCLUSIONS: We recommend using inactivated virus collection solution to preserve and transport samples and testing preferably within 6 hours to reduce false negatives of NAT results. John Wiley and Sons Inc. 2023-09-03 /pmc/articles/PMC10561591/ /pubmed/37661301 http://dx.doi.org/10.1002/jcla.24956 Text en © 2023 The Authors. Journal of Clinical Laboratory Analysis published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Duan, Xiuzhi Huang, Letao Wang, Xuchu Ping, Ying Yu, Pan Liu, Weiwei Xie, Yiyi Tao, Zhihua How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing |
title | How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing |
title_full | How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing |
title_fullStr | How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing |
title_full_unstemmed | How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing |
title_short | How to better select SARS‐CoV‐2 preservation solution of virus nucleic acid testing |
title_sort | how to better select sars‐cov‐2 preservation solution of virus nucleic acid testing |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561591/ https://www.ncbi.nlm.nih.gov/pubmed/37661301 http://dx.doi.org/10.1002/jcla.24956 |
work_keys_str_mv | AT duanxiuzhi howtobetterselectsarscov2preservationsolutionofvirusnucleicacidtesting AT huangletao howtobetterselectsarscov2preservationsolutionofvirusnucleicacidtesting AT wangxuchu howtobetterselectsarscov2preservationsolutionofvirusnucleicacidtesting AT pingying howtobetterselectsarscov2preservationsolutionofvirusnucleicacidtesting AT yupan howtobetterselectsarscov2preservationsolutionofvirusnucleicacidtesting AT liuweiwei howtobetterselectsarscov2preservationsolutionofvirusnucleicacidtesting AT xieyiyi howtobetterselectsarscov2preservationsolutionofvirusnucleicacidtesting AT taozhihua howtobetterselectsarscov2preservationsolutionofvirusnucleicacidtesting |